SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

lululemon athletica, Inc. engages in the business of designing, distributing, and retailing technical athletic apparel, footwear, and accessories. It operates through the following segments: Company-Operated Stores, Direct to Consumer, and Other. The company was founded by Dennis James Wilson in 1998 and is headquartered in Vancouver, Canada.

Lululemon Athletica inc.

Lululemon Athletica Inc

Lululemon shares are facing significant downward pressure as investors react to a downward revision in full-year guidance and lackluster demand in North America. Community discussion is polarized, with some traders viewing the sharp sell-off as a value-buying opportunity given the company's cash position, while others fear the brand is losing its competitive edge to rivals and struggling with broader retail headwinds.

Ethereum is a global, open-source platform for decentralized applications. In other words, it is a decentralized blockchain platform that enables developers to build and deploy smart contracts and applications without central authority control. Unlike Bitcoin, which primarily functions as digital currency, Ethereum operates as a programmable global computer where developers can create any type of decentralized service.   The platform hosts over $14 billion in DeFi applications with hundreds of thousands of active users across financial protocols, NFT marketplaces, and gaming platforms. Its transition to Proof of Stake in September 2022 reduced energy consumption by over 99%, addressing environmental concerns while strengthening network security.  The network operates through thousands of independent validator nodes that process transactions and execute smart contracts on the Ethereum Virtual Machine. Smart contracts are self-executing programs written in Solidity that automatically carry out agreements when conditions are met, eliminating intermediaries like banks or brokers.   Validators stake ETH as collateral to propose and validate blocks, earning rewards for honest participation while facing penalties for malicious behavior. The EIP-1559 upgrade introduced a dynamic base fee mechanism that burns ETH with each transaction, creating deflationary pressure during high network activity when more ETH is burned than issued to validators.  Vitalik Buterin proposed Ethereum in 2013, but seven co-founders helped build it, including Gavin Wood who created Solidity and the EVM technical specification, and Joseph Lubin who founded ConsenSys. The project launched in July 2015 after raising over $18 million through crowdfunding, quickly becoming the largest blockchain developer community. Major milestones include the 2020 Beacon Chain launch, the 2021 London hard fork implementing fee burning, and the 2022 Merge to Proof of Stake.   Ether (ETH) serves multiple functions: paying transaction fees (gas), staking to secure the network and earn 3-5% annual yields, serving as collateral in DeFi protocols, and purchasing NFTs and digital assets. The asset is increasingly adopted by traditional institutions, with publicly traded companies adding ETH to corporate treasuries to generate staking yields while maintaining blockchain exposure, and in 2024, the SEC approved spot Ethereum ETFs, allowing traditional investors to gain exposure through conventional brokerage accounts.  Ethereum's roadmap focuses on dramatically increasing transaction capacity to over 100,000 per second, reducing confirmation times, and enhancing decentralization while maintaining security against future threats like quantum computing.

Ethereum

Ethereum is facing intense volatility and downward pressure as the broader crypto market suffers from widespread liquidations, leading to a heated debate among investors about whether this represents a terminal decline or a rare accumulation opportunity. The community is sharply divided, with bulls pointing to historical cycles and institutional interest as reasons to hold, while skeptics emphasize the lack of real-world utility and the potential for a deeper, protracted correction.

Zcash is a privacy-focused cryptocurrency that uses trustless zero-knowledge proofs to enable fully encrypted transactions while maintaining blockchain transparency and security. It was the first cryptocurrency to implement zero-knowledge encryption for private peer-to-peer payments, addressing the fundamental privacy gap in traditional cryptocurrencies that expose transaction details publicly.   With a fixed supply of 21 million ZEC and a halving schedule similar to Bitcoin, Zcash allows users to prove transactions are valid without revealing sensitive information like wallet balances, transaction amounts, or participant identities, making it suitable for everyday payments, long-term savings, and cross-border money transfers where financial confidentiality matters.  The protocol operates on its own blockchain currently using Proof-of-Work consensus, though it's evolving toward Proof-of-Stake through the planned "Crosslink" upgrade to enhance security, scalability, and energy efficiency. Zcash employs trustless zero-knowledge proofs (Halo) within its Orchard shielded pool to verify transactions without revealing sender, receiver, or amount information.   Users can choose between transparent public transactions and shielded private transactions through Unified Addresses, which work with both types. The network is faster and cheaper than Bitcoin, with new blocks mined every 75 seconds and transaction fees typically just a fraction of a cent. Privacy adoption has surged in 2025, with over 30% of total ZEC supply now held in fully shielded pools.  Zcash was created by a group of scientists in 2013 who initially proposed Zerocoin as a privacy extension to Bitcoin before building a standalone protocol. The ecosystem operates with a self-funded development model where block rewards support independent teams through the Zcash Community Grants Committee and a new Coinholder-Controlled Fund.

Zcash

Zcash is at the center of a heated community debate after a security researcher identified a historical vulnerability in the Orchard pool that theoretically permitted the creation of counterfeit tokens. While developers have already patched the bug and the network remains operational, investors are sharply divided between those panic-selling over potential supply integrity concerns and bulls who view the price dip as a historic buying opportunity.

Advisorshares Trust - AdvisorShares Pure US Cannabis ETF

AdvisorShares Pure US Cannabis ETF

AdvisorShares Pure US Cannabis ETF is trending as investors monitor ongoing corporate restructuring and uplisting efforts by major MSOs, while community debate intensifies over the impact of federal regulatory hearings and the influence of market makers on share price stability.

Planet Labs PBC provides daily data and insights about earth. It offers a web-geo platform with satellite data available and foundational analytics to derive insights to make decisions. The company is founded by William S. Marshall and Robert H. Schingler in 2010 and is headquartered in San Francisco, CA.

Planet Labs PBC - Ordinary Shares - Class A

Planet Labs PBC

Planet Labs is trending as investors digest a strong earnings report and the company's expanding role in defense and geospatial AI, with the stock drawing significant attention from institutional holders like Google. While some traders express frustration over recent stock offerings and short-term volatility, the community is actively debating the stock's growth potential fueled by the broader space sector momentum and upcoming industry milestones.

Merlin, Inc. is a US-based developer of cost-effective, takeoff-to-touchdown autonomy for both legacy and next-generation airborne systems. Its aircraft-agnostic, AI-powered software is purpose-built for military and civil programs and is powering an expanding range of missions and aircraft, proven through numerous autonomous flights from test facilities worldwide. The company works with military customers to address national security challenges through safe and reliable autonomy. Merlin is headquartered in Boston, MA.

Merlin Inc.

Merlin Inc. is seeing intense investor focus following a successful critical design review for its autonomous C-130J program with the U.S. Special Operations Command, which validates the company's AI-powered flight architecture. The community is actively discussing the stock's potential for a massive short squeeze due to its low float and limited shares available to borrow, while also debating its long-term viability as an AI-driven aerospace defense play.

Trulieve Cannabis Corp. engages in the provision of medical cannabis products and services. It cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. The company was founded by Kim Rivers & Jason Pernell on September 17, 1940 and is headquartered in Tallahassee, FL.

Trulieve Cannabis Corp - Ordinary Shares (Sub Voting)

Trulieve Cannabis

Trulieve Cannabis is seeing heightened investor attention as market participants focus on the company's potential to uplist to a major exchange following strategic corporate restructuring to separate medical and recreational assets. The community is actively debating the impact of upcoming legislative reforms and the company's significant medical cannabis footprint, which many see as a primary catalyst for institutional interest and long-term sector leadership.

Keel Infrastructure Corp. engages in building artificial intelligence focused data centers and energy assets. It focuses on infrastructure and energy required to support high-performance computing and artificial intelligence workloads. The company was founded on April 1, 2026 and is headquartered in New York, NY.

Keel Infrastructure Corp.

Keel Infrastructure Corp

Keel Infrastructure is trending as investors digest the recent $400 million convertible notes offering, with the community actively debating whether the dilution-protected capital is a strategic move to secure hyperscaler leases or a short-term bearish signal. While some retail traders are concerned about potential price volatility, institutional-focused discussions highlight the offering as a standard, growth-oriented 'war chest' buildout similar to successful plays in the AI infrastructure sector.

Seres Therapeutics, Inc. engages in the development of biological drugs through microbiome therapeutics platform. Its product pipeline includes SER-109, SER-287, SER-301, and SER-401. The company was founded by Geoffrey von Maltzahn, David A. Berry, and Noubar B. Afeyan on October 18, 2010 and is headquartered in Cambridge, MA.

Seres Therapeutics Inc

Seres Therapeutics is seeing intense trading volume and bullish sentiment as investors speculate on a potential buyout or major partnership, with many pointing to the company's clinical pipeline and prior strategic ties as catalysts. The community is actively debating whether these price movements signal an imminent deal or a tactical pump, while balancing optimism over the firm's microbiome platform against concerns regarding its financial runway.

DocuSign, Inc. engages in the provision of cloud-based electronic signature solutions, which helps companies and individuals securely collect information, automate data workflows, and sign anything. The firm automates manual and paper-based processes allowing users to manage all aspects of documented business transactions including identity management, authentication, digital signature, forms and data collection, collaboration, workflow automation, and storage. Its products include eSignature, CLM, Gen for Salesforce, Document Generation, Standards-Based Signatures, Notary and Web Forms. The company was founded by Thomas H. Gonser and Court Lorenzini in 2003 and is headquartered in San Francisco, CA.

DocuSign Inc

DocuSign shares are facing downward pressure as investors weigh recent quarterly results against cautious guidance, fueling community debate over the company's long-term competitive moat in an AI-driven landscape. While some market participants express frustration over the stock's muted performance despite earnings beats and share buyback activity, others argue that the valuation has become attractive for long-term holders as the company pivots toward its Intelligent Agreement Management platform.

statis crypto Watchlist

Bitcoin

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

SDZNY or UTHR: Which Is the Better Value Stock Right Now?

SDZNY vs. UTHR: Which Stock Is the Better Value Option?

United Therapeutics Corporation (UTHR): Renaissance Technologies Likes This Biotech Stock

United Therapeutics Corporation (UTHR): Renaissance Technologies Likes This Biotech Stock...

United Therapeutics Corporation to Present at the Jefferies Global Healthcare Conference

United Therapeutics Corporation (Nasdaq: UTHR) announced today that James Edgemond, Chief Financial Officer and Treasurer, will provide a company overview and update on Wednesday, June 3, 2026, from 12:45 to 1:15 p.m. EST, at the Jefferies Global Healthcare Conference in New York. The presentation...

UTHR Holds As Tyvaso Shows 33% Lower Worsening Risk In Rare Lung Scarring Disease

Equity

United Therapeutics Corporation Announces TETON-1 Study of Tyvaso Published in The New England Journal of Medicine and Presented at ATS 2026

United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that the New England Journal of Medicine has published the full results of its TETON-1 study, as well as...

Baidu, Brady And 3 Stocks To Watch Heading Into Monday

U.S. stock futures down on Monday. Focus on Baidu, Brady, United Therapeutics for earnings. XP and Ryanair to report after markets close.read more...

United Therapeutics Corporation Announces ADVANCE OUTCOMES Study of Ralinepag Presented at ATS 2026

United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that full results of its ADVANCE OUTCOMES study are being presented today during the Breaking News: 2026...

United Therapeutics Corporation Announces FDA Clearance to Proceed with UHeart Xenotransplantation Clinical Trial

United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that the U.S. Food and Drug Administration (FDA) has granted clearance under the companys Investigational...

CPRX or UTHR: Which Is the Better Value Stock Right Now?

CPRX vs. UTHR: Which Stock Is the Better Value Option?

Varda Space Industries and United Therapeutics Collaborate to Advance Microgravity-Enabled Treatments for Rare Pulmonary Disease

Varda Space Industries and United Therapeutics Collaborate to Advance Microgravity-Enabled Treatments for Rare Pulmonary Disease Varda Space Industries and United Therapeutics Collaborate to Advance...

United Therapeutics Corp. is a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening conditions. Its products include Adcirca, Orenitram, Remodulin, TYVASO, and Unituxin. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.

UTHRUnited Therapeutics Corp

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest UTHR News